跳至主要内容
临床试验/IRCT20171125037624N2
IRCT20171125037624N2招募中2 期

Molecular investigation of hepatitis c virus before and after direct acting antiviral (DAA) therapy in thalasemia patients

Iran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Thalassemia major patient that have chronic HCV infection more than 18 years old, HCV/HBV co-infection, HCC or compensated cirrhosis without any limitation were included.

排除标准

  • Patients that have HIV/HCV co-infection and pregnant women were excluded.

研究者

相似试验